Effect of curcumin on inflammatory markers and disease activity in patients with rheumatoid arthritis: A meta-analysis

Curcumin supplementation was associated with statistically and clinically relevant improvements in disease activity and systemic inflammatory markers in RA. These findings support curcumin as a promising adjunctive therapeutic strategy, though larger, exposure-verified trials with extended follow-up remain required to validate long-term treatment effects and inform clinical implementation.